MedDataX Logo

Feasibility Study: Ulthera® System for the Treatment of Moderate to Severe Facial Acne

NCT01591304 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2017-11-24

No results posted yet for this study

Summary

This study will evaluate the effectiveness of Ultherapy for the treatment of facial acne.

Conditions

  • Facial Acne

Interventions

DEVICE

Ulthera System Treatment

Focused ultrasound energy delivered below the surface of the skin.

Sponsors & Collaborators

  • Ulthera, Inc

    lead INDUSTRY

Principal Investigators

  • Girish Munavalli, M.D. · Dermatology, Laser & Vein Specialists of the Carolinas

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2014-06-30
Completion
2014-07-31

Countries

  • United States

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01591304 on ClinicalTrials.gov